Active Pharmaceutical Ingredient Market Set to Exceed USD 306.1 Billion By 2027 | CAGR: 7.1% “Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2020 - 2027”
Active Pharmaceutical Ingredient Market Estimate & Forecast to 2027 The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 2027 according to a new study by Polaris Market Research. The report gives a detailed insight into current market dynamics and provides analysis on future market growth. Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body. Drug products are composed of various components, API is the primary ingredient of a drug product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline form, thermo-dynamically. The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth. Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For instance, according to a report published in March 2020, by World Health Organization (WHO), the number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market. Copyright Š Polaris Market Research & Consulting LLP 2018. All Rights Reserved
2
Active Pharmaceutical Ingredient Market Scope By Product Type
By Form
By Manufacturer Type
By Application
• Monoclonal Antibodies • Immunoglobulin • Cytokines • Insulin • Peptide Hormones • Blood Factors • Peptide Antibiotics • Vaccines • Small Molecule Antibiotics • Highly Potent Active Pharmaceutical Ingredient (HPAPI) • Others
• Aqueous • NonAqueous • Dry Powder
• Captive • Merchant
• • • • • • • • • •
Cardiology Oncology CNS & Neurology Orthopedic Endocrinology Pulmonology Gastroenterology Nephrology Ophthalmology Others
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved
Request for sample
By Region
• North America (U.S., Canada) • Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) • Latin America (Brazil, Mexico, Argentina) • MEA (Saudi Arabia, UAE, Israel, South Africa) 3
Active Pharmaceutical Ingredient Market Estimate & Forecast to 2027 Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market. Access Research Report On Active Pharmaceutical Ingredient Market Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades. Major players in the market are strengthening their capabilities to enhance their product portfolio and further establish their market place. For instance, on July, 2020, Advert International signed an agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is expected to leverage their operational and financial resources across the globe to scale RA Chem Pharma. Copyright Š Polaris Market Research & Consulting LLP 2018. All Rights Reserved
4
Active Pharmaceutical Ingredient Market Size
Request for Sample Copyright Š Polaris Market Research & Consulting LLP 2018. All Rights Reserved
5
Active Pharmaceutical Ingredient Market Study – Engagement Options
Buy Now – Click Here! Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here! Regional analysis Segmentation analysis Industry outlook Competitive landscape
Speak To Analyst – Click Here! Get your doubts clear Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here! Get free sample pages Understand report structure Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved
6
About Us Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to e present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Â Web: www.polarismarketresearch.com
Copyright Š Polaris Market Research & Consulting LLP 2018. All Rights Reserved
7
Thank You! Contact Us : Polaris Market Research 30 Wall Street 8th Floor, New York City, NY 10005, United States E mail Id: sales@polarismarketresearch.com Phone: +1-646-568-9980